search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Infection Control & Hospital Epidemiology


ability to test for LD in house using urine antigen tests (UAT), 21 respondents (72%) reported using respiratory culture, and 8 respondents (28%) reported using multipathogen molecular assays. However, 19 respondents (66%) indicated that routine LD testing for hospital-acquired pneumonia was limited to non– culture-based tests (eg, urine antigen tests or molecular assay), and only 4 respondents (14%) reported always conducting bac- terial culture in conjunction with nonculture tests. Moreover, 19 respondents (66%) had an established water management plan (WMP) for both potable and nonpotable water; 8 respondents (28%) reported a WMP was in development, 1 respondent (3%) had a WMP for nonpotable water only (with planning underway for potable water), and 1 respondent (3%) had no WMP. The facility without a WMP reported having no cases of LD in the past 5 years. To monitor potable water quality, 18 of 28 respondents (64%) reported routinely measuring disin- fectant levels (eg, residual chlorine), 17 respondents (61%) reported routinely measuring temperature, and 15 rsepondents (54%) reported routinely measuring pH level. In addition, 17 respondents (61%) reported routinely testing for Legionella pre- sence as part of their WMP. Having an existing WMP and per- forming routine tests on potable water were more frequently reported among larger facilities and those with transplant units, compared to those without (Table 1). Existing WMPs covering potable and nonpotable water were also more prevalent among the 9 facilities reporting a healthcare-associated LD case in the previous 5 years than in facilities not reporting a healthcare- associated case: 8 of 9 (88.9%) versus 11 of 20 (55%). Regarding personnel actively engaged inWMPdevelopment, the


most commonly reported domains of expertise were infection control (93%) and facilities and engineering (90%); risk


1471


management and public health staff were less frequently involved (Table 2). Although most facilities reported awareness of ASHRAE Standard 188 (97%) and the CDC toolkit (89%)—andusedthese to develop their facility's WMP—fewer were aware of the American Industrial Hygiene Association (AIHA)'s Legionella guidelines from 2015. Moreover, 24% of facilities reported not having conducted a risk assessment to identify areas within their infrastructure sus- ceptible to Legionella growth, as outlined in these standards.


Discussion


In this sample of acute-care hospitals, the reported prevalence of established WMP and awareness of key LD prevention guidance documents was high. Nearly two-thirds of facilities reported already having established a WMP covering both potable and nonpotable water, though we did not determine their adequacy or comprehensiveness. This is substantially more than the 27% of hospitals in Minnesota that reported having a WMP before the release of the CMS directive in June 2017.6 Close to 60% of respondents reported having conducted a risk assessment for Legionella since 2014, yet some of these assess- ments likely occurred before publication of new prevention guidelines. As facilities continue refining their WMP, conducting periodic risk assessments with emphasis on Legionella prevention will be a continued priority. For diagnosing LD, the UAT was the most prevalent diag-


nostic, with 86% indicating capacity to conduct UATs at their facility. This proportion is substantially higher than the 18.8% of acute-care hospitals reporting this capability in 2013.7 Although this increase could signal general improvements in LD diagnostic


Table 1. Differences in Legionella Prevention Activities by Presence of Transplant Unit, Facility Size and Facility Type, 29 SHEA Research Network Respondents, October–November 2017


LD related activity WMP is in place


Cultures for routine diagnostics Always/Sometimes Rarely/Never


LD identified within 5 y


Routine potable water testing includes:c pH


Temperature Legionella presence


L. pneumophila presence only Aware of ASHRAE 188c Aware of CDC tool kitc Aware of AIHA guidancec


Transplant Unit, No. (%) 14 (78) 2 (33) Facility Bed Size, No. (%) 8 (80) 10 (77) Hospital Type, No. (%)


No (n=11) Yes (n=18) 100–249 (n=6) 250–459 (n=10) ≥500 (n=13) Academica (n=17) Otherb (n=12) 6 (55)


13 (76)


6 (54) 5 (45) 9 (82)


4 (40) 5 (50) 5 (50) 3 (30) 9 (90) 9 (90) 5 (50)


14 (78) 4 (22)


15 (83)


11 (61) 12 (67) 12 (67) 4 (22)


18 (100) 16 (89) 11 (61)


5 (83) 1 (17) 4 (67)


3 (50) 4 (67) 2 (33) 2 (33)


6 (100) 6 (100) 4 (67)


Industrial Hygiene Association. aAcademic medical center or university-affiliated academic medical center. bCommunity teaching hospital with academic affiliation, community hospital, federal non-military hospital. cOnly 28 respondents to these questions.


6 (60) 4 (40) 8 (80)


5 (56) 6 (67) 7 (78) 1 (11)


9 (100) 8 (89) 5 (56)


9 (70) 4 (31)


12 (92)


7 (54) 7 (54) 8 (62) 4 (31)


12 (92) 11 (85) 7 (54)


14 (82) 3 (18)


14 (82) 9 (53)


10 (59) 11 (65) 4 (24)


17 (100) 15 (88) 10 (59)


7 (58)


6 (50) 6 (50)


10 (83)


6 (55) 7 (64) 6 (55) 3 (27)


10 (91) 10 (91) 6 (55)


Note. SHEA, Society for Healthcare Epidemiology of America; LD, Legionnaires’ disease; WMP, water management plan; CDC, Centers for Disease Control and Prevention; AIHA, American


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124